Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).

1 Feb 2011

New research finding shows strong relationship between gut bacteria and fatty liver

The more we learn about biology, the closer we get to being able to treat disease - and the more complicated our understanding of disease itself becomes. A new research finding showing a strong relationship between complex microbial ecologies in human intestines and the common but serious medical condition known as fatty liver illustrates this paradox.

1 Feb 2011

Venture philanthropist invests $3.5 million to thwart Alzheimer's disease

Retired San Francisco real estate developer Douglas Rosenberg says he has a new job - helping to find a cure for Alzheimer's disease. Through the Ellen and Douglas Rosenberg Foundation, the venture philanthropist is betting at least $3.5 million that Buck faculty Dale Bredesen, MD has the correct take on how to thwart the memory robbing disease that affects over 5 million Americans.

31 Jan 2011

Scientists convert adult skin cells into cardiomyocytes using direct reprogramming strategy

Scripps Research Institute scientists have converted adult skin cells directly into beating heart cells efficiently without having to first go through the laborious process of generating embryonic-like stem cells. The powerful general technology platform could lead to new treatments for a range of diseases and injuries involving cell loss or damage, such as heart disease, Parkinson's, and Alzheimer's disease.

30 Jan 2011

HPN President announces gift to UCLA to advance research for Neural Regeneration

Dr. Richard Merkin, President and CEO of Heritage Provider Network, and the Merkin Family Foundation announce the generous gift to the UCLA Department of Neurology at the David Geffen School of Medicine at UCLA to advance research for Neural Regeneration.

29 Jan 2011

Elderly Americans most likely to have one or more cognitive disorders: AHRQ

Slightly over 5 percent of the nearly 39 million Americans age 65 and older in 2007 reported one or more cognitive disorders, such as senility or dementia, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

29 Jan 2011

Adeona to sell 2.85 million common stock at $1.40 per share

Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.

29 Jan 2011

CIHR announces $8.6 million for new research on Alzheimer's disease

the Honourable Leona Aglukkaq, Minister of Health, and the Honourable Julian Fantino, Minister of State for Seniors, today announced $8.6 million for new research on Alzheimer's disease.

29 Jan 2011

Research provides new clues for compulsive behavior, cognitive defects linked with LND

Research from the University of California, San Diego School of Medicine provides new clues for the compulsive behavior and cognitive defects associated with a rare childhood neurological disease called Lesch-Nyhan Disease.

29 Jan 2011

Neuralstem ends litigation with ReNeuron

Neuralstem, Inc. announced that it has reach a settlement with ReNeuron, Ltd. ending litigation between the parties.

28 Jan 2011

Connectome remains dynamic during development, says Scripps Research

Connected highways of nerve cells carry information to and from different areas of the brain and the rest of the nervous system. Scientists are trying to draw a complete atlas of these connections-sometimes referred to as the "connectome"-to gain a better understanding of how the brain functions in health and disease.

28 Jan 2011

Misaligned research, medical challenges and harsh economics thwart efforts against Alzheimer's disease

Misaligned research, medical challenges and harsh economics are thwarting efforts to slow the destructive course of Alzheimer's disease in the United States, according to a trio of nationally regarded Alzheimer's researchers writing a "Perspective" in Jan. 27 issue of the journal Neuron.

28 Jan 2011

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

The Alzheimer's Drug Discovery Foundation announced today that it has awarded a grant of $195,000 to ALS Biopharma, LLC to develop therapeutics targeted at clearing toxic proteins implicated in Alzheimer's disease.

28 Jan 2011

New molecular player responsible for regulation of appetite and metabolism

A study by researchers at Mayo Clinic's campus in Florida and Washington University School of Medicine adds a new twist to the body of evidence suggesting human obesity is due in part to genetic factors. While studying hormone receptors in laboratory mice, neuroscientists identified a new molecular player responsible for the regulation of appetite and metabolism.

28 Jan 2011

Study aims to determine risk of dementia, cognitive decline in middle-aged people

University of North Carolina at Chapel Hill researchers are co-leading a national study to examine whether middle-aged people's physical health influences their risk of dementia later in life.

28 Jan 2011

'Alzheimer's has the power to bring the country to its financial knees'

Starting this year, more than 10,000 baby boomers a day will turn 65. As these baby boomers age, one of out of eight of them will develop Alzheimer's – a devastating, costly, heartbreaking disease. Increasingly for these Baby Boomers, it will no longer be their grandparents and parents who have Alzheimer's – it will be them.

27 Jan 2011

How estrogen decreases risk and delays onset and progression of Alzheimer's disease

An influential article in the journal Progress in Neurobiology provided one of the first comprehensive reviews of how estrogen potentially can protect against Alzheimer's disease and other neurological disorders.

27 Jan 2011

Triggering CD45 molecule blocks early development of AD

A new target for the prevention of adverse immune responses identified as factors in the development of Alzheimer's disease (AD) has been discovered by researchers at the University of South Florida's Department of Psychiatry and the Center of Excellence for Aging and Brain Repair.

27 Jan 2011

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2010.

27 Jan 2011

Potential therapy to enhance memory and prevent loss of long-term memory

Researchers from Mount Sinai School of Medicine have identified a therapy that may enhance memory and prevent the loss of long-term memory. The research is published in the January 27th issue of Nature.

27 Jan 2011

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

New research finding shows strong relationship between gut bacteria and fatty liver

Venture philanthropist invests $3.5 million to thwart Alzheimer's disease

Scientists convert adult skin cells into cardiomyocytes using direct reprogramming strategy

HPN President announces gift to UCLA to advance research for Neural Regeneration

Elderly Americans most likely to have one or more cognitive disorders: AHRQ

Adeona to sell 2.85 million common stock at $1.40 per share

CIHR announces $8.6 million for new research on Alzheimer's disease

Research provides new clues for compulsive behavior, cognitive defects linked with LND

Neuralstem ends litigation with ReNeuron

Connectome remains dynamic during development, says Scripps Research

Misaligned research, medical challenges and harsh economics thwart efforts against Alzheimer's disease

ALS Biopharma receives ADDF grant to develop therapeutics against Alzheimer's disease

New molecular player responsible for regulation of appetite and metabolism

Study aims to determine risk of dementia, cognitive decline in middle-aged people

'Alzheimer's has the power to bring the country to its financial knees'

How estrogen decreases risk and delays onset and progression of Alzheimer's disease

Triggering CD45 molecule blocks early development of AD

Abbott fourth quarter worldwide sales increase 13.4% to nearly $10 billion

Potential therapy to enhance memory and prevent loss of long-term memory

Aneuro: A Year of Neuroscience in Review eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Aneuro: A Year of Neuroscience in Review eBook

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in